GlassScriptPhysician profile
Michael R Geer
NPI 1669492526
$2,249.89
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $897 · 2021: $252.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $544.66 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $374.14 | 2019-2020 | |
| Amarin Pharma, INC. | $258.50 | 2019-2021 | |
| Novo Nordisk INC | $224.28 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $182.26 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.50 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $107.06 | 2019-2021 | |
| Pfizer INC. | $98.27 | 2019 | |
| Janssen Pharmaceuticals, INC | $92.56 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $41.81 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $40.01 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $35.40 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.15 | 2019-2020 | |
| Aegerion Pharmaceuticals, INC. | $15.94 | 2019 | |
| Currax Pharmaceuticals LLC | $14.20 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $14.02 | 2019 | |
| Redhill Biopharma INC. | $13.84 | 2021 | |
| Lundbeck LLC | $12.26 | 2020 | |
| Portola Pharmaceuticals, LLC | $11.80 | 2019 | |
| Lilly USA, LLC | $11.12 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Geer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.